HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

L'Oreal

This article was originally published in The Rose Sheet

Executive Summary

First half cosmetics sales rose 10.7%, or 13.5% excluding currency effects, the company announced July 15. L'Oreal's dermatology business shot up 40.5% on published figures, and 43.6% without the impact of exchange rates. The consolidation of the cosmetics and dermatology business had a positive impact of .8%. Consolidated sales increased 11% to $5.48 bil. Sales increased 13.8% excluding currency effects. Currency had a negative effect of 2.8%, compared to a positive impact of .6% in the second half of 1998

Latest Headlines
See All
UsernamePublicRestriction

Register

RS006906

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel